Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,230.71
(
-0.16%
)
Brent Oil
101.66
(
0.99%
)
Bitcoin
78,188.60
(
0.73%
)
News Focus
News Focus
Post# of 44698
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Millstone

Send PM Follow Ignore
Followers 85
Posts 1770
Boards Moderated 0
Alias Born 09/03/2009

Millstone

Re: Whalatane post# 20266

Saturday, 09/12/2020 7:45:57 PM

Saturday, September 12, 2020 7:45:57 PM

Post# of 44698
The current IV trial of Aviptadil is a Phase II/III. It is a registration trial and a COMBINED Phase 2 and 3, meaning at the trials end in 3-4 weeks, it will be the end of the PHASE 3.

No doubt and EUA will be applied for (and granted), and FDA will follow with a full approval.

This release from NeuroRx confirms that the intravenous Aviptadil trial includes Phase 3: https://www.neurorxpharma.com/press-releases/press-release-phase2-3covid-19/



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RLFTF News
More RLFTF News